SCHEMBL1644208

SCHEMBL1644208

CC(=O)c1cnc2cc(C(F)(F)F)c(F)cc2c1Cl

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNQ3 O43525 2/20 0.38
KCNQ2 O43526 2/20 0.38
KCNE1 P15382 2/20 0.38
KCNQ1 P51787 2/20 0.38
KIF11 P52732 1/20 0.37
MELK Q14680 6/20 0.35
GRM4 Q14833 1/20 0.34
XPO1 O14980 2/20 0.34
NFKB1 P19838 2/20 0.34
ATF1 P18846 1/20 0.34
THRB P10828 1/20 0.34
NR3C1 P04150 1/20 0.34
KMT2A Q03164 2/20 0.33
ASPH Q12797 1/20 0.33
ALDH1A1 P00352 1/20 0.33
MEN1 O00255 1/20 0.33
MAPT P10636 1/20 0.33
JUN P05412 1/20 0.33
NFKB2 Q00653 1/20 0.33
RELA Q04206 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1645669 0.85 KIF11 (0.38) KCNQ3KCNQ2KCNE1KCNQ1KIF11
SCHEMBL1285850 0.83 KMT2A (0.49) THRBKMT2AALDH1A1MEN1MAPT
SCHEMBL1643933 0.76 MELK (0.38) MELKGRM4KMT2AMEN1MAPT
SCHEMBL1643326 0.75 TSHR (0.36) MELKGRM4XPO1NFKB1ATF1
SCHEMBL2720016 0.74 CSF1R (0.41) KCNQ3KCNQ2KCNE1KCNQ1
SCHEMBL2718101 0.74 TSHR (0.43) MELKTHRBALDH1A1MAPT
SCHEMBL7083535 0.72 KDM4E (0.42) KMT2AASPHALDH1A1MEN1
SCHEMBL23575518 0.71 KMT2A (0.46) THRBKMT2AALDH1A1MEN1MAPT
SCHEMBL4785818 0.71 MEN1 (0.50) THRBKMT2AALDH1A1MEN1MAPT
SCHEMBL2718832 0.71 LMNA (0.56) MELKKMT2AALDH1A1MEN1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120088746-A1 AMIDE DERIVATIVES AS ION-CHANNEL LIGANDS AND PHARMACEUTICAL COMPOSITIONS AND METHODS OF USING THE SAME PFIZER INC. (US) 2012-04-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120088746-A1 AMIDE DERIVATIVES AS ION-CHANNEL LIGANDS AND PHARMACEUTICAL COMPOSITIONS AND METHODS OF USING THE SAME TRPV1, TRPA1, TRPV2 KCNQ3 59/4885KCNQ2 46/4885KCNE1 82/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.